Netherlands Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare)
|
Major Players
|
Netherlands Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Netherlands was valued at USD 280 million in 2025 and is estimated at USD 285 million in 2026.
- The market size is expected to grow to USD 310 million by 2032.
- Market to register a CAGR of around 1.46% during 2026-32.
- Product Shares
- Systemic analgesics grabbed market share of 80%.
- Competition
- More than 15 companies are actively engaged in producing analgesics in Netherlands.
- Top 5 companies acquired around 60% of the market share.
- Healthypharm BV, Reckitt Benckiser Healthcare BV, Heel Biologische Geneesmiddelen BV, AS Watson (Health & Beauty Benelux), Haleon Netherlands BV etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 95% of the market.
Netherlands Analgesics Market Outlook
Netherlands Analgesics Market size was valued at USD 280 million in 2025 and is projected to grow from USD 285 million in 2026 to USD 310 million by 2032, exhibiting a CAGR of 1.46% during the forecast period. Growth remains steady as demand for pain relief products stays supported by regular self care use, while improving household spending creates room for better value performance and stronger interest in more advanced and convenient pain relief formats.
Demand continues to be supported by the country’s ageing population, which keeps the need for everyday pain relief visible across regular self care. Older adults are more likely to face joint pain, back pain, and other recurring discomforts, which helps maintain stable use of trusted products. At the same time, systemic analgesics lead the product landscape with around 80% share, supported by the broad use of oral pain relief products for headaches, fever, joint pain, and other common symptoms.
Price pressure still shapes purchase behaviour, as consumers notice price changes quickly in this frequently used category. This makes lower priced and private label products more competitive against branded options. Alongside this, a stronger digital confidence trend is influencing how analgesics are selected, as consumers increasingly use online information and digital tools to compare products, understand symptoms, and make more informed self care decisions.
By sales channel, retail offline holds the leading position with around 95% share, as physical pharmacies and stores remain the most trusted places to buy pain relief products. Quick access, familiar buying habits, and confidence in regulated store based medicine access keep offline purchasing central. This strong channel presence continues to support stable and practical category expansion through the forecast period.

Netherlands Analgesics Market Growth DriverAgeing Keeps Everyday Pain Relief Relevant
A growing older population supports steady demand for analgesics in the Netherlands. Older adults are more likely to face joint pain, back pain, and other recurring discomforts, which keeps everyday pain relief important in regular self care. This also supports continued use of familiar products that are trusted for reliable and practical symptom relief.
Statistics Netherlands reports that in early 2025, the Netherlands has 3.76 million people aged 65 and over, slightly more than the 3.72 million people under 20. CBS also states that at the start of 2025, 15.6% of the population is aged 65–79 and 5.2% is aged 80 or over. This age structure keeps pain management needs visible across the country.
Netherlands Analgesics Market ChallengeValue Pressure Strengthens Low-Cost Competition
Price pressure remains a key challenge for analgesics in the Netherlands. Consumers buy these products regularly, so price changes are noticed quickly, and that makes it easier for private label and lower priced options to compete with branded products. In a mature category, even small differences in price can affect repeat purchases and brand loyalty.
CBS reports that consumer prices in the Netherlands rise by 3.3% in 2025 compared with 2024. At the same time, the Dutch government says it is negotiating more competitive medicine prices and notes this could deliver annual savings of €155 million. This shows how strongly value for money remains part of medicine purchasing decisions.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Netherlands Analgesics Market TrendDigital Self-Care Becomes More Visible
A clearer trend in the Netherlands is the stronger role of digital confidence in self care and medicine choice. Consumers increasingly use digital tools and online information to compare products, understand symptoms, and make informed purchase decisions. This supports growing interest in analgesics that promise convenience, speed, and clear product communication.
The European Commission’s 2025 Digital Decade Country Report says the Netherlands has a strong digital skills profile, and 84% of Dutch citizens say digitalisation of public and private services is making their lives easier. The Dutch Medicines Information Bank is also updated weekly, giving consumers official product information, revised leaflets, and authorisation updates.
Netherlands Analgesics Market OpportunityBetter Spending Conditions Open Room for Premium Formats
Improving household spending creates a clear opening for higher value analgesics in the Netherlands. When consumers feel less pressure to trade down, brands have more room to position faster acting, more advanced, or more convenient formats. This supports products that offer added value through quicker relief, easier use, or more targeted pain management.
CBS reports that real household disposable income rises by 2.7% in 2025, while Dutch retail turnover is 3.6% higher in 2025 than in 2024. This firmer spending backdrop supports demand for products that go beyond basic pain relief and gives manufacturers more room to promote differentiated formats.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Netherlands Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the Product is Systemic Analgesics, holding around 80% of the Netherlands Analgesics Market in value terms. This segment remains ahead because oral pain relief products are still the most familiar choice for headaches, fever, joint pain, and other common discomforts. Their broad use and trusted profile keep them central to regular self care.
Its leading position is supported by the country’s ageing profile. CBS states that in early 2025, the Netherlands has 3.76 million people aged 65 and over, and this group now slightly outnumbers people under 20. Since older consumers are more likely to experience recurring aches and pains, systemic analgesics continue to see broad and regular use.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the Sales Channel is Retail Offline, accounting for around 95% of the Netherlands Analgesics Market in value terms. This channel leads because consumers still rely on physical pharmacies and stores for quick access, familiar purchase routines, and trusted advice when choosing pain relief products. Offline buying remains especially important for everyday medicines where reassurance matters.
Retail offline stays ahead because Dutch medicine access remains strongly tied to regulated pharmacy channels. The Dutch government states that fake medicines are widely sold online and advises consumers to first check whether an online supplier is reliable. The Medicines Evaluation Board also continues to provide official medicine information through its national information bank. This keeps store based purchasing more trusted for analgesics.
List of Companies Covered in Netherlands Analgesics Market
The companies listed below are highly influential in the Netherlands analgesics market, with a significant market share and a strong impact on industry developments.
- Healthypharm BV
- Reckitt Benckiser Healthcare BV
- Heel Biologische Geneesmiddelen BV
- AS Watson (Health & Beauty Benelux)
- Haleon Netherlands BV
- Royal Ahold NV
- Bayer Consumer Care BV
- Imgroma BV
- Leidapharm BV
- Remark Pharma BV
Competitive Landscape
In 2025, analgesics in Netherlands recorded positive retail value growth, driven by consumers returning to busy lifestyles and seeking effective pain management solutions, alongside price increases linked to higher production and distribution costs. AS Watson (Health & Beauty Benelux) led the market with a 19.7% value share, followed by Haleon Netherlands BV at 15.7%, with strong competition from private label offerings perceived as better value for money. acetaminophen remained the most widely used analgesic, while ibuprofen saw notable growth due to its effectiveness and availability in fast-acting formats such as liquid capsules. Demand was further supported by growing self-medication, an ageing population, and increased consumer awareness, while innovation in formats and the expansion of e-commerce strengthened accessibility, even as pharmacy sales declined due to reduced reimbursement and shifting purchasing behaviour.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Netherlands Analgesics Market Policies, Regulations, and Standards
- Netherlands Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Netherlands Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Netherlands Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Netherlands Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- AS Watson (Health & Beauty Benelux)
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Haleon Netherlands BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Royal Ahold NV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bayer Consumer Care BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Imgroma BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Healthypharm BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Reckitt Benckiser Healthcare BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Heel Biologische Geneesmiddelen BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Leidapharm BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- OTC Medical BV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- AS Watson (Health & Beauty Benelux)
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











